These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24610824)

  • 1. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
    Li X; Wan X; Chen H; Yang S; Liu Y; Mo W; Meng D; Du W; Huang Y; Wu H; Wang J; Li T; Li Y
    Clin Cancer Res; 2014 May; 20(9):2312-25. PubMed ID: 24610824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
    He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
    J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells.
    Cagle P; Niture S; Srivastava A; Ramalinga M; Aqeel R; Rios-Colon L; Chimeh U; Suy S; Collins SP; Dahiya R; Kumar D
    Sci Rep; 2019 Jul; 9(1):9776. PubMed ID: 31278310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
    Liu H; Song X; Hou J; Zhao Z; Chang J
    DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-155 promotes the proliferation of prostate cancer cells by targeting annexin 7.
    Cai ZK; Chen Q; Chen YB; Gu M; Zheng DC; Zhou J; Wang Z
    Mol Med Rep; 2015 Jan; 11(1):533-8. PubMed ID: 25339368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
    Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
    Qiu T; Zhou X; Wang J; Du Y; Xu J; Huang Z; Zhu W; Shu Y; Liu P
    FEBS Lett; 2014 Apr; 588(7):1168-77. PubMed ID: 24613927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-Regulation of MicroRNA-133b Suppresses Apoptosis of Lens Epithelial Cell by Up-Regulating BCL2L2 in Age-Related Cataracts.
    Zhang F; Meng W; Tong B
    Med Sci Monit; 2016 Nov; 22():4139-4145. PubMed ID: 27802259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
    Wang L; Liu C; Li C; Xue J; Zhao S; Zhan P; Lin Y; Zhang P; Jiang A; Chen W
    Gene; 2015 Nov; 572(2):252-8. PubMed ID: 26164758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.
    Wen D; Li S; Ji F; Cao H; Jiang W; Zhu J; Fang X
    Tumour Biol; 2013 Apr; 34(2):793-803. PubMed ID: 23296701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
    Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
    J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression.
    Murata T; Takayama K; Katayama S; Urano T; Horie-Inoue K; Ikeda K; Takahashi S; Kawazu C; Hasegawa A; Ouchi Y; Homma Y; Hayashizaki Y; Inoue S
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):356-61. PubMed ID: 20820187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.
    Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
    Cancer Lett; 2015 Dec; 369(1):58-66. PubMed ID: 26276722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.